THE PROGNOSIS IN OSTEO-SARCOMA - NORWEGIAN NATIONAL DATA

被引:0
作者
HARVEI, S [1 ]
SOLHEIM, O [1 ]
机构
[1] NORWEGIAN RADIUM HOSP,DEPT GEN,OSLO,NORWAY
关键词
D O I
10.1002/1097-0142(19811015)48:8<1719::AID-CNCR2820480806>3.0.CO;2-J
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1719 / 1723
页数:5
相关论文
共 20 条
[1]  
Armitage P., 1975, SEQUENTIAL MED TRIAL
[2]  
CADE S, 1955, J R Coll Surg Edinb, V1, P79
[3]  
CORTES EP, 1978, CANCER TREAT REP, V62, P271
[4]  
FRIEDMAN M A, 1972, Journal of Surgical Oncology, V4, P482, DOI 10.1002/jso.2930040512
[5]  
GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203
[6]   ADJUVANT METHOTREXATE AND CITROVORUM-FACTOR TREATMENT OF OSTEOGENIC SARCOMA [J].
JAFFE, N ;
FREI, E ;
TRAGGIS, D ;
BISHOP, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) :994-997
[7]  
JAFFE N, 1978, CANCER TREAT REP, V62, P259
[8]  
JAFFE N, 1978, P AM ASSOC CANC RES, V19, P400
[9]  
LEE ES, 1975, CLIN RADIOL, V26, P5
[10]  
MIKE V, 1978, PROG CANCER RES THER, V6, P283